Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael A. Metzger currently holds 491,690 shares of Syndax Pharmaceuticals Inc (SNDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael A. Metzger has been a net seller of SNDX stock. They have purchased $1.5K and sold $15.2M worth of shares.
Michael A. Metzger's most recent insider trade was on Feb 9, 2026, when they sold 17,159 shares at $21.03 per share.
Michael A. Metzger serves as Executive at Syndax Pharmaceuticals Inc (SNDX). They have executed 80 insider transactions totaling $15.2M over their tenure at the company.
Michael A. Metzger holds the position of Executive at Syndax Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Michael A. Metzger has shown a selling trading pattern, with $1.5K in total purchases and $15.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael A. Metzger was on Feb 7, 2024, when they purchased $4.8M worth of SNDX shares. This transaction involved 214,500 shares at $22.28 per share.
Michael A. Metzger currently owns 491,690 shares of Syndax Pharmaceuticals Inc (SNDX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael A. Metzger's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael A. Metzger has 80 Form 4 filings on record as an insider at Syndax Pharmaceuticals Inc.
Set alerts for Michael A. Metzger and 40,000+ other insiders.